Dermapharm Holding SE (DMP.DE)

EUR 37.75

(3.14%)

Total Assets Summary of Dermapharm Holding SE

Dermapharm Holding SE's latest annual total assets in 2023 was 2.18 Billion EUR , up 54.55% from previous year.
Dermapharm Holding SE's latest quarterly total assets in 2024 Q2 was 2.2 Billion EUR , up 1.57% from previous quarter.
Dermapharm Holding SE reported annual total assets of 1.41 Billion EUR in 2022, up 0.42% from previous year.
Dermapharm Holding SE reported annual total assets of 1.4 Billion EUR in 2021, up 14.91% from previous year.
Dermapharm Holding SE reported quarterly total assets of 2.2 Billion EUR for 2024 Q2, up 1.57% from previous quarter.
Dermapharm Holding SE reported quarterly total assets of 2.11 Billion EUR for 2023 Q2, down -2.51% from previous quarter.

Annual Total Assets Chart of Dermapharm Holding SE (2023 - 2013)

Historical Annual Total Assets of Dermapharm Holding SE (2023 - 2013)

Year	Total Assets	Total Assets Growth
2023	2.18 Billion EUR	54.55%
2022	1.41 Billion EUR	0.42%
2021	1.4 Billion EUR	14.91%
2020	1.22 Billion EUR	17.18%
2019	1.04 Billion EUR	48.3%
2018	704.58 Million EUR	69.65%
2017	415.3 Million EUR	33.24%
2016	311.69 Million EUR	5.07%
2015	296.66 Million EUR	-10.26%
2014	330.59 Million EUR	-5.54%
2013	349.97 Million EUR	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	2.17 Billion EUR	-0.48%
2024 Q2	2.2 Billion EUR	1.57%
2023 Q2	2.11 Billion EUR	-2.51%
2023 Q3	2.15 Billion EUR	2.17%
2023 FY	2.18 Billion EUR	54.55%
2023 Q1	2.16 Billion EUR	53.45%
2023 Q4	2.18 Billion EUR	1.12%
2022 Q2	1.41 Billion EUR	-3.06%
2022 Q4	1.41 Billion EUR	-2.66%
2022 FY	1.41 Billion EUR	0.42%
2022 Q1	1.46 Billion EUR	3.86%
2022 Q3	1.45 Billion EUR	2.45%
2021 Q1	1.27 Billion EUR	4.28%
2021 FY	1.4 Billion EUR	14.91%
2021 Q4	1.4 Billion EUR	4.96%
2021 Q3	1.34 Billion EUR	4.92%
2021 Q2	1.27 Billion EUR	0.06%
2020 Q2	1.2 Billion EUR	10.52%
2020 Q4	1.22 Billion EUR	0.26%
2020 Q1	1.08 Billion EUR	4.11%
2020 Q3	1.22 Billion EUR	1.58%
2020 FY	1.22 Billion EUR	17.18%
2019 Q3	1.01 Billion EUR	5.73%
2019 FY	1.04 Billion EUR	48.3%
2019 Q1	961.82 Million EUR	36.51%
2019 Q2	960.61 Million EUR	-0.13%
2019 Q4	1.04 Billion EUR	2.87%
2018 Q2	688.39 Million EUR	1.32%
2018 FY	704.58 Million EUR	69.65%
2018 Q4	704.58 Million EUR	1.91%
2018 Q3	691.35 Million EUR	0.43%
2018 Q1	679.4 Million EUR	63.59%
2017 Q4	415.3 Million EUR	-3.11%
2017 Q3	428.64 Million EUR	0.0%
2017 Q1	- EUR	-100.0%
2017 FY	415.3 Million EUR	33.24%
2016 FY	311.69 Million EUR	5.07%
2016 Q4	311.69 Million EUR	0.0%
2015 FY	296.66 Million EUR	-10.26%
2014 FY	330.59 Million EUR	-5.54%
2013 FY	349.97 Million EUR	0.0%

Peer Total Assets Comparison of Dermapharm Holding SE

Name	Total Assets	Total Assets Difference
MPH Health Care AG	266.35 Million EUR	-719.78%
Apontis Pharma AG	57.5 Million EUR	-3697.4%
Evotec SE	2.29 Billion EUR	5.026%
MERCK Kommanditgesellschaft auf Aktien	49.12 Billion EUR	95.555%
PharmaSGP Holding SE	131.29 Million EUR	-1563.002%
SynBiotic SE	34.91 Million EUR	-6153.207%